Moritz Wildgruber Selected Research

Neoplasms (Cancer)

5/2024	Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.
4/2024	Multiparametric MRI for characterization of the tumour microenvironment.
4/2024	SPFS: SNR peak-based frequency selection method to alleviate resolution degradation in MPI real-time imaging.
4/2024	Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.
11/2023	Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.
10/2023	Radiofrequency Ablation-Induced Tumor Growth Is Suppressed by MicroRNA-21 Inhibition in Murine Models of Intrahepatic Colorectal Carcinoma.
9/2023	Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.
7/2023	Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
1/2023	Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy.
1/2023	Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moritz Wildgruber Research Topics

Disease

38	Neoplasms (Cancer) 05/2024 - 01/2013
12	Hemorrhage 01/2024 - 03/2017
10	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2013
9	Vascular Malformations 04/2024 - 02/2018
8	Inflammation (Inflammations) 04/2024 - 08/2012
8	Stroke (Strokes) 01/2023 - 01/2019
7	Ischemic Stroke 01/2023 - 01/2020
7	Myocardial Infarction 01/2020 - 11/2009
6	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2017
6	Thrombosis (Thrombus) 01/2022 - 12/2019
6	Infarction (Infarctions) 01/2021 - 01/2013
5	Arteriovenous Malformations (Arteriovenous Malformation) 01/2023 - 02/2018
5	Atherosclerosis 11/2020 - 08/2012
4	Liver Neoplasms (Liver Cancer) 11/2023 - 09/2020
4	Atherosclerotic Plaque (Atheroma) 05/2023 - 08/2012
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
4	Hepatic Encephalopathy 10/2021 - 02/2020
4	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021 - 11/2020
3	Infections 08/2023 - 12/2017
3	Liver Diseases (Liver Disease) 01/2023 - 06/2021
3	Pain (Aches) 01/2023 - 06/2017
3	Portal Hypertension 06/2022 - 09/2021
3	Sepsis (Septicemia) 01/2021 - 01/2016
3	Wounds and Injuries (Trauma) 01/2020 - 01/2019
3	Rupture 12/2018 - 01/2016
2	Hyperaldosteronism (Conn Syndrome) 01/2024 - 01/2023
2	Hypertrophy 12/2023 - 12/2022
2	Carcinogenesis 10/2023 - 12/2017
2	Ascites 09/2023 - 06/2022
2	COVID-19 08/2023 - 08/2020
2	Disease Progression 01/2023 - 01/2023
2	Adenocarcinoma 12/2022 - 07/2021
2	Necrosis 01/2022 - 01/2013
2	Hemangioma (Angioma) 01/2022 - 03/2019
2	Cicatrix (Scar) 04/2018 - 03/2014
2	Synovitis 05/2017 - 01/2014
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2013 - 08/2012
2	Cardiomyopathies (Cardiomyopathy) 08/2013 - 08/2012
1	Sarcopenia 04/2024
1	Sarcoma (Soft Tissue Sarcoma) 04/2024
1	Neuroblastoma 04/2024
1	Sinistral Portal Hypertension 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Lymphoma (Lymphomas) 11/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2016
8	Contrast MediaIBA 12/2022 - 03/2014
5	AlbuminsIBA 06/2021 - 08/2013
4	Sorafenib (BAY 43-9006)FDA Link 04/2024 - 01/2022
4	Hemoglobins (Hemoglobin)IBA 09/2021 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2017
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2019
3	GadoliniumIBA 01/2022 - 03/2014
2	SirtuinsIBA 04/2024 - 01/2022
2	Yttrium-90IBA 02/2024 - 12/2019
2	Apolipoproteins E (ApoE)IBA 05/2023 - 11/2020
2	ethylene-vinyl alcohol copolymerIBA 09/2022 - 12/2021
2	Interleukin-6 (Interleukin 6)IBA 02/2022 - 06/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2021
2	Polidocanol (Laureth)FDA Link 01/2022 - 01/2021
2	FibrinIBA 11/2021 - 01/2019
2	LipidsIBA 09/2021 - 12/2018
2	BilirubinIBA 06/2021 - 05/2021
2	Endothelins (Endothelin)IBA 11/2020 - 01/2020
2	YttriumIBA 09/2020 - 12/2019
2	gadofluorine PIBA 01/2020 - 04/2018
2	Polyurethanes (Polyurethane)IBA 01/2020 - 12/2016
2	Gadolinium DTPA (Magnevist)FDA Link 04/2018 - 03/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2017 - 01/2014
2	IntegrinsIBA 01/2017 - 08/2012
2	SiliconesIBA 01/2017 - 01/2016
1	Starch (Cornstarch)IBA 05/2024
1	MAP Kinase Kinase 1IBA 04/2024
1	Mitogen-Activated Protein KinasesIBA 04/2024
1	Blood Proteins (Serum Proteins)IBA 02/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024
1	salicylhydroxamic acid (SHAM)IBA 10/2023

Therapy/Procedure

38	Therapeutics 04/2024 - 08/2012
10	Thrombectomy 01/2023 - 01/2019
8	Transjugular Intrahepatic Portasystemic Shunt 09/2023 - 02/2020
8	Sclerotherapy 04/2022 - 06/2017
7	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2022 - 12/2019
5	Aftercare (After-Treatment) 01/2023 - 12/2018
5	Catheters 01/2020 - 01/2016
4	Microspheres (Microsphere) 05/2024 - 12/2019
4	Liver Transplantation 04/2024 - 01/2013
3	Immunotherapy 04/2024 - 01/2023
3	Radiotherapy 04/2024 - 01/2022
3	Radiofrequency Ablation 10/2023 - 01/2023
3	Ligation 04/2018 - 12/2012
2	Brachytherapy 02/2024 - 09/2023
2	Hepatectomy 12/2023 - 12/2022
2	Combined Modality Therapy 01/2023 - 01/2022
2	Therapeutic Embolization 07/2022 - 02/2018
2	Stents 01/2022 - 12/2019
2	Precision Medicine 01/2021 - 01/2021
2	Secondary Prevention 01/2021 - 01/2017
1	Splenectomy 01/2024
1	Pancreaticoduodenectomy 01/2024